HMD vs NEU

ASX Healthcare sector comparison — updated 22 Jul 2026 — Healthcare sector

HMD

HERAMED FPO [HMD]

46LOW

NEU

NEUREN FPO NZ [NEU]

46LOW

Score Breakdown

HMD NEU
Technical
39
63
Catalyst
55
50
Sentiment
50
50
Fundamental
33
62
Momentum
44
26
Risk Gate
37
43

Key Metrics

HMD Metric NEU
$44.0MMarket Cap$2.1B
627KAvg Volume (20d)662K
N/AShort Interest+4.7%
$0.05552-Week High$22.985
$0.01252-Week Low$11.000
-2.6%Daily Change-1.1%
$0.037Reference Price$16.760
-223.2%ROE+8.7%
N/AProfit Margin+47.1%

Active Signals

HMD Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.5 quarters)
Very high P/S ratio (102.0x)
Piotroski F-Score weak (3/9, low-confidence approx)

NEU Signals

MACD momentum is losing steam
Stochastic just turned bullish from a low level — early reversal sign
Drifting lower — down 4.4% over the last 5 days
Beating the Small Ords index — relative strength of 1.36, so it's outpacing the pack
Volatility is contracting — like a spring being compressed, breakouts often follow
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)

Ask Scout AI to compare HMD and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HMD vs NTI →HMD vs NUZ →HMD vs PKP →HMD vs PKY →HMD vs RCE →
HMD Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).